Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Direct observation of uterotonic drug use at public health facility-based deliveries in four districts in India.

Stanton CK, Deepak NN, Mallapur AA, Katageri GM, Mullany LC, Koski A, Mirzabagi E.

Int J Gynaecol Obstet. 2014 Oct;127(1):25-30. doi: 10.1016/j.ijgo.2014.04.014. Epub 2014 Jun 12.

PMID:
25026891
2.

Knowledge, attitudes, and practices related to uterotonic drugs during childbirth in Karnataka, India: a qualitative research study.

Deepak NN, Mirzabagi E, Koski A, Tripathi V.

PLoS One. 2013 Apr 29;8(4):e62801. doi: 10.1371/journal.pone.0062801. Print 2013.

3.

Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India.

Stanton C, Nand DN, Koski A, Mirzabagi E, Brooke S, Grady B, Mullany LC.

BMC Pregnancy Childbirth. 2014 Nov 13;14:386. doi: 10.1186/s12884-014-0386-y.

4.

Use of prophylactic uterotonics during the third stage of labor: a survey of provider practices in community health facilities in Sierra Leone.

Natarajan A, Ahn R, Nelson BD, Eckardt M, Kamara J, Kargbo S, Kanu P, Burke TF.

BMC Pregnancy Childbirth. 2016 Jan 28;16:23. doi: 10.1186/s12884-016-0809-z.

5.

Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review.

Gizzo S, Patrelli TS, Gangi SD, Carrozzini M, Saccardi C, Zambon A, Bertocco A, Fagherazzi S, D'Antona D, Nardelli GB.

Reprod Sci. 2013 Sep;20(9):1011-9. doi: 10.1177/1933719112468951. Epub 2013 Jan 7. Review.

PMID:
23296037
6.

Uterotonic use during childbirth in Uttar Pradesh: accounts from community members and health providers.

Mirzabagi E, Deepak NN, Koski A, Tripathi V.

Midwifery. 2013 Aug;29(8):902-10. doi: 10.1016/j.midw.2012.11.004. Epub 2013 Feb 15.

PMID:
23415370
7.

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.

Westhoff G, Cotter AM, Tolosa JE.

Cochrane Database Syst Rev. 2013 Oct 30;(10):CD001808. doi: 10.1002/14651858.CD001808.pub2. Review.

PMID:
24173606
8.

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia.

Smith JM, Baawo SD, Subah M, Sirtor-Gbassie V, Howe CJ, Ishola G, Tehoungue BZ, Dwivedi V.

BMC Pregnancy Childbirth. 2014 Jun 4;14:189. doi: 10.1186/1471-2393-14-189.

9.

Misoprostol use during the third stage of labor.

Joy SD, Sanchez-Ramos L, Kaunitz AM.

Int J Gynaecol Obstet. 2003 Aug;82(2):143-52. Review.

PMID:
12873774
10.

Timing of prophylactic uterotonics for the third stage of labour after vaginal birth.

Soltani H, Hutchon DR, Poulose TA.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD006173. doi: 10.1002/14651858.CD006173.pub2. Review.

PMID:
20687079
11.
12.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD005457. doi: 10.1002/14651858.CD005457.pub4. Review.

PMID:
22513931
13.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005457. doi: 10.1002/14651858.CD005457.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD005457.

PMID:
22336812
14.

A mixed-methods study of barriers and facilitators to the implementation of postpartum hemorrhage guidelines in Uganda.

Braddick L, Tuckey V, Abbas Z, Lissauer D, Ismail K, Manaseki-Holland S, Ditai J, Stokes T.

Int J Gynaecol Obstet. 2016 Jan;132(1):89-93. doi: 10.1016/j.ijgo.2015.06.047. Epub 2015 Sep 28.

PMID:
26475077
15.

Prostaglandins for prevention of postpartum haemorrhage.

Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ.

Cochrane Database Syst Rev. 2004;(1):CD000494. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD000494.

PMID:
14973959
16.

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour.

Gülmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, Abdel-Aleem H, Cheng L, Hofmeyr G, Lumbiganon P, Unger C, Prendiville W, Pinol A, Elbourne D, El-Refaey H, Schulz K; WHO Collaborative Group To Evaluate Misoprostol in the Management of the Third Stage of Labour.

Lancet. 2001 Sep 1;358(9283):689-95.

PMID:
11551574
17.

Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan.

Smith JM, Dimiti A, Dwivedi V, Ochieng I, Dalaka M, Currie S, Luka EE, Rumunu J, Orero S, Mungia J, McKaig C.

Int J Gynaecol Obstet. 2014 Nov;127(2):183-8. doi: 10.1016/j.ijgo.2014.05.016. Epub 2014 Jul 9.

PMID:
25051905
18.

Prostaglandins for preventing postpartum haemorrhage.

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD000494. doi: 10.1002/14651858.CD000494.pub4. Review.

PMID:
22895917
19.

A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.

Priya GP, Veena P, Chaturvedula L, Subitha L.

Arch Gynecol Obstet. 2015 Dec;292(6):1231-7. doi: 10.1007/s00404-015-3763-5. Epub 2015 May 20.

PMID:
25990482
20.

Umbilical vein injection for the routine management of third stage of labour.

Mori R, Nardin JM, Yamamoto N, Carroli G, Weeks A.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006176. doi: 10.1002/14651858.CD006176.pub2. Review.

PMID:
22419311

Supplemental Content

Support Center